# Study to Assess the Safety, Tolerability, and Pharmacokinetics of PXL770 in Healthy Subjects.

> **NCT05441904** · PHASE1 · COMPLETED · sponsor: **Poxel SA** · enrollment: 16 (actual)

## Conditions studied

- NASH - Nonalcoholic Steatohepatitis

## Interventions

- **DRUG:** PXL770

## Key facts

- **NCT ID:** NCT05441904
- **Lead sponsor:** Poxel SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-08
- **Primary completion:** 2021-03-29
- **Final completion:** 2021-03-29
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2022-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05441904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05441904, "Study to Assess the Safety, Tolerability, and Pharmacokinetics of PXL770 in Healthy Subjects.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05441904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*